Results 201 to 210 of about 358,107 (405)

Physiologically Based Pharmacokinetic Modeling and Simulation to Support a Change in the FDA‐Labeled Dosing Frequency of RHB‐105 Low‐Dose Rifabutin Triple Therapy for Helicobacter pylori Eradication

The Journal of Clinical Pharmacology, EarlyView.
Abstract Patient adherence is vital for Helicobacter pylori eradication. Simplifying therapy dosing schedules may promote patient adherence, enhance treatment success rates, and help mitigate the development of antibiotic resistance. We aimed to assess plasma and intragastric rifabutin, amoxicillin, and omeprazole concentrations comparing two dosing ...
Nimish Vakil, Colin W. Howden, Shailja C. Shah, Kuan‐Fu Chen, Elliot Offman, June S. Almenoff, Kely L. Sheldon   +6 more
wiley   +1 more source

A comparison of efficacy and safety of potassium‐competitive acid blocker and proton pump inhibitor in gastric acid‐related diseases: A systematic review and meta‐analysis

Journal of Gastroenterology and Hepatology, Volume 37, Issue 12, Page 2217-2228, December 2022., 2022
Abstract Background and Aim Potassium‐competitive acid blocker (PCAB) is a recent alternative to proton pump inhibitor (PPI) for potent acid suppression. The current systematic review and meta‐analysis aimed to compare the efficacy and safety of PCAB versus PPI in treating gastric acid‐related diseases.
Daniel Martin Simadibrata, Ari Fahrial Syam, Yeong Yeh Lee   +2 more
wiley   +1 more source

Is Helicobacter pylori the cause of dyspepsia? [PDF]

, 1992
Bjørn Bernersen, Roar Johnsen, Leif Bostad, Bjørn Straume, Albrecht Sommer, P. G. Burhol   +5 more
openalex   +1 more source

Urine-Based ELISA for the Detection of Helicobacter pylori IgG Antibody and Comparison with Other Invasive Methods.

, 1970
Md Din-ul Islam, Sufi HZ Rahman, SM Shamsuzzaman, Naima Muazzaman, Nasim Ahmed, Shamsun Nahar   +5 more
openalex   +2 more sources

Local and systemic immune responses in murine Helicobacter felis active chronic gastritis [PDF]

, 1993
James G. Fox, Michael C. Blanco, James C. Murphy, Nancy S. Taylor, A Lee, Zita Kabók, Jacques Pappo   +6 more
openalex   +1 more source

Study of <i>Helicobacter hepaticus</i> in gallbladders with cholelithiasis and its sensitivity pattern

, 1970
SB Pradhan
openalex   +2 more sources

Inoculation of barrier-born pigs with Helicobacter pylori: a useful animal model for gastritis type B [PDF]

, 1990
Lars Engstrand, Sven Gustavsson, Anne Jørgensen, Anna Schwan, Annika Scheynius   +4 more
openalex   +1 more source

Prevalence of hepatitis B virus amongst refugees, asylum seekers and internally displaced persons in low‐ and middle‐income countries: A systematic review

Journal of Viral Hepatitis, Volume 30, Issue 1, Page 4-18, January 2023., 2023
Abstract Hepatitis B, caused by the hepatitis B virus (HBV), is a global public health issue that affects 290 million people worldwide. Most people with hepatitis B are in low‐ and middle‐income countries (LMIC), where health systems and resources are often constrained.
Caroline Lee, Theophilus I. Emeto, Nick Walsh   +2 more
wiley   +1 more source

In vitro inhibition of Helicobacter pylori urease with non and semi fermented Camellia sinensis [PDF]

, 2009
Purpose: Helicobacter pylori is the etiological agent in duodenal and peptic ulcers. The growing problem of antibiotic resistance by the organism demands the search for novel compounds, especially from natural sources.
Amirmozafari, N., Ghaemi, A., Hamdi, K., Nazari, R., Ordouzadeh, N., Shoae Hassani, A.   +5 more
core  

Role of Crush Cytology for the Detection of Helicobacter Pylori in Gastroduodenal Diseases

, 1970
Kamrul Ahsan, MZ Hossain, MR Uddin
openalex   +2 more sources